Lincoln Capital Corp increased its position in shares of UnitedHealth Group Inc (NYSE:UNH) by 2.1% during the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 8,300 shares of the healthcare conglomerate’s stock after buying an additional 170 shares during the period. UnitedHealth Group makes up about 1.5% of Lincoln Capital Corp’s investment portfolio, making the stock its 24th biggest position. Lincoln Capital Corp’s holdings in UnitedHealth Group were worth $1,804,000 as of its most recent SEC filing.

A number of other institutional investors have also recently added to or reduced their stakes in UNH. Benjamin F. Edwards & Company Inc. increased its position in shares of UnitedHealth Group by 140.6% in the 3rd quarter. Benjamin F. Edwards & Company Inc. now owns 14,779 shares of the healthcare conglomerate’s stock worth $3,212,000 after purchasing an additional 8,636 shares during the last quarter. Taylor Hoffman Wealth Management increased its position in shares of UnitedHealth Group by 146.4% in the 3rd quarter. Taylor Hoffman Wealth Management now owns 3,287 shares of the healthcare conglomerate’s stock worth $714,000 after purchasing an additional 1,953 shares during the last quarter. BigSur Wealth Management LLC increased its position in shares of UnitedHealth Group by 111.1% in the 3rd quarter. BigSur Wealth Management LLC now owns 10,450 shares of the healthcare conglomerate’s stock worth $2,271,000 after purchasing an additional 5,500 shares during the last quarter. Principle Wealth Partners LLC increased its position in shares of UnitedHealth Group by 16.1% in the 3rd quarter. Principle Wealth Partners LLC now owns 3,741 shares of the healthcare conglomerate’s stock worth $813,000 after purchasing an additional 519 shares during the last quarter. Finally, Brasada Capital Management LP increased its position in shares of UnitedHealth Group by 16.6% in the 3rd quarter. Brasada Capital Management LP now owns 2,329 shares of the healthcare conglomerate’s stock worth $506,000 after purchasing an additional 332 shares during the last quarter. 85.66% of the stock is currently owned by hedge funds and other institutional investors.

Shares of NYSE:UNH traded up $0.51 during trading on Friday, reaching $256.97. 2,161,274 shares of the company’s stock traded hands, compared to its average volume of 4,544,972. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.70 and a quick ratio of 0.67. UnitedHealth Group Inc has a 12 month low of $208.07 and a 12 month high of $287.94. The company has a 50 day moving average of $234.76 and a 200-day moving average of $241.05. The stock has a market capitalization of $237.20 billion, a P/E ratio of 19.95, a price-to-earnings-growth ratio of 1.33 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $3.88 earnings per share for the quarter, beating analysts’ consensus estimates of $3.75 by $0.13. UnitedHealth Group had a net margin of 5.57% and a return on equity of 25.30%. The business had revenue of $60.35 billion during the quarter, compared to the consensus estimate of $59.84 billion. During the same quarter in the prior year, the firm earned $3.41 EPS. The company’s revenue for the quarter was up 6.7% compared to the same quarter last year. Equities research analysts predict that UnitedHealth Group Inc will post 14.96 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th will be paid a dividend of $1.08 per share. This represents a $4.32 dividend on an annualized basis and a yield of 1.68%. UnitedHealth Group’s payout ratio is 33.54%.

Several equities research analysts have recently weighed in on UNH shares. Jefferies Financial Group downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating and dropped their target price for the stock from $300.00 to $235.00 in a research report on Thursday, October 10th. Barclays set a $260.00 target price on shares of UnitedHealth Group and gave the stock a “buy” rating in a research report on Tuesday, October 8th. UBS Group dropped their target price on shares of UnitedHealth Group from $281.00 to $257.00 and set a “neutral” rating for the company in a research report on Thursday, October 17th. Citigroup dropped their target price on shares of UnitedHealth Group from $299.00 to $286.00 and set a “buy” rating for the company in a research report on Wednesday, October 16th. Finally, Cleveland Research reaffirmed a “buy” rating on shares of UnitedHealth Group in a research report on Monday, July 15th. Five research analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company. The stock currently has an average rating of “Buy” and an average target price of $283.84.

In other UnitedHealth Group news, Director Richard T. Burke sold 25,000 shares of the business’s stock in a transaction dated Wednesday, October 16th. The shares were sold at an average price of $236.56, for a total transaction of $5,914,000.00. Following the completion of the transaction, the director now directly owns 163,331 shares of the company’s stock, valued at approximately $38,637,581.36. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CAO Thomas E. Roos sold 1,177 shares of the business’s stock in a transaction dated Thursday, November 7th. The shares were sold at an average price of $255.04, for a total transaction of $300,182.08. Following the transaction, the chief accounting officer now directly owns 21,687 shares of the company’s stock, valued at $5,531,052.48. The disclosure for this sale can be found here. Insiders have sold a total of 33,177 shares of company stock valued at $7,842,582 over the last three months. 0.87% of the stock is currently owned by company insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Read More: What is a dead cat bounce?

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.